Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing-Reference-Cited by-同舟云学术

Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing

Published:2023-01 Issue: Volume:152 Page:106347
ISSN:0010-4825
Container-title:Computers in Biology and Medicine
language:en
Short-container-title:Computers in Biology and Medicine

Author:

Falchetti Marcelo,Delgobo Marina^ORCID,Zancanaro Helena,Almeida Karoline,das Neves Raquel Nascimento^ORCID,dos Santos Barbara,Stefanes Natália Marcéli,Bishop Alexander,Santos-Silva Maria Cláudia,Zanotto-Filho Alfeu^ORCID

Funder

Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference68 articles.

1. Modulation of oxidative stress as an anticancer strategy;Gorrini;Nat. Rev. Drug Discov.,2013

2. ROS stress in cancer cells and therapeutic implications;Pelicano;Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother.,2004

3. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation;Radenkovic;Biochem. Pharmacol.,2017

4. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system;Nordberg;Free Radic. Biol. Med.,2001

5. TrxR1 as a potent regulator of the Nrf2-Keap1 response system;Cebula;Antioxidants Redox Signal.,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of circulating proteins in multiple myeloma risk: a Mendelian randomization study;2024-08-02

2. Erastin Enhances Bortezomib Efficacy Through ROS-Mediated DNA Damage Repair and Ferroptosis in Multiple Myeloma;J BIOL REG HOMEOS AG;2024

3. The Inhibition Mechanism of Auranofin on Thioredoxin Reductase 1 at the Molecular Level: A New Use of the Old Drug;2024

4. Benzophenanthridine Alkaloid Chelerythrine Elicits Necroptosis of Gastric Cancer Cells via Selective Conjugation at the Redox Hyperreactive C-Terminal Sec498 Residue of Cytosolic Selenoprotein Thioredoxin Reductase;Molecules;2023-09-28

5. Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs;Redox Biology;2023-06